BiondVax Pharmaceuticals Ltd ADR (BVXV) Stock
BVXV is no longer traded. BiondVax Pharmaceuticals Ltd ADR was delisted from the Nasdaq in November 2023.
Prices on this page are historical; the last trade was November 8, 2023 at $0.69.
BiondVax Pharmaceuticals Ltd ADR stock price history
BVXV final trading statistics
- Final close
- $0.69
- Final trading day
- Nov 8, 2023
- Market cap at delisting
- $2.52M
- Shares outstanding
- 3.65M
- Final 52-week range
- $0.62 – $11.49
- Avg. volume (final 3 mo.)
- 29,542
- All-time high (split-adj.)
- $5110.00 · Jul 2020
- All-time low (split-adj.)
- $6.20 · Oct 2023
- Return since IPO
- -98.3%
- Beta
- 2.37
- Book value / share
- -$1.96
- Price / book
- -0.35
BiondVax Pharmaceuticals Ltd ADR annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$531.0K | — |
| FY2021 | $2.75M | -$50.8M | -$3.86 |
| FY2020 | $0.00 | $6.8M | -$41.66 |
| FY2019 | $0.00 | -$124.1M | — |
| FY2018 | $0.00 | -$23.3M | -$0.13 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About BiondVax Pharmaceuticals Ltd ADR
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
BiondVax Pharmaceuticals Ltd ADR stock FAQ
What happened to BiondVax Pharmaceuticals Ltd ADR stock?
BiondVax Pharmaceuticals Ltd ADR stock was delisted from the Nasdaq. Its final close was $0.69 on November 8, 2023.
Is BVXV stock still trading?
No. BVXV was delisted from the Nasdaq in November 2023 and no longer trades on a U.S. exchange.
What was the last price of BVXV stock?
BVXV closed at $0.69 on its final trading day, November 8, 2023, for a market value of about $2.52M.
What were BiondVax Pharmaceuticals Ltd ADR's revenue and earnings in its last full fiscal year?
BiondVax Pharmaceuticals Ltd ADR reported revenue of $0.00 and net income of -$531.0K in fiscal 2022, its last full year as a public company.
When did BiondVax Pharmaceuticals Ltd ADR go public?
BiondVax Pharmaceuticals Ltd ADR stock began trading on May 12, 2015.